In a previous article the important role of protein crystallography in the optimisation of drug candidates was highlighted. An essential part of this process is establishing robust protein crystallisation systems that can be used for both soaking and co-crystallisation experiments. This may mean producing many hundreds of X-ray quality crystals in a reproducible and timely manner and, despite the progress made in expression and purification of proteins for structural studies, this is not always trivial. This article outlines the practice of Automated Matrix Seeding and its increasing importance in the pharmaceutical industry.
Sorry, this page is available to members only.
If you have not registered with us yet, why not
register today for FREE and receive exclusive online access. Interested in receiving European Pharmaceutical Review in print? Subscribe today and guarantee the next six issues delivered direct to your desk, plus gain exclusive access online.
